Diffuse large B-cell lymphoma on the back of a patient with AIDS:: Successful treatment by the CD20 monoclonal antibody rituximab

被引：1
|
作者：
Voigtländer, C
Harrer, T
Schneider, L
Schulze-Koops, H
Niedobitek, G
Lüftl, M
机构：
[1] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany
[2] Univ Hosp Erlangen, Dept Med 3, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2005年 / 44卷 / 11期
关键词：
D O I：
10.1111/j.1365-4632.2005.02649.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：976 / 978
页数：4
相关论文
共 50 条
  • [31] Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy
    Clarke, LE
    Bayerl, MG
    Ehmann, WC
    Helm, KF
    JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (07) : 459 - 462
  • [32] Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma
    McLinden, Gretchen P.
    Avery, Anne C.
    Gardner, Heather L.
    Hughes, Kelley
    Rodday, Angie M.
    Liang, Kexuan
    London, Cheryl A.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2024, 38 (03) : 1666 - 1674
  • [33] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [34] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    International Journal of Hematology, 2002, 76 : 411 - 419
  • [35] Rituximab and chemotherapy in diffuse large B-cell lymphoma
    Sonet, Anne
    Bosly, Andre
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 719 - 726
  • [36] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [37] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Yasser Abou Mourad
    Ali Taher
    Aref Chehal
    Ali Shamseddine
    Annals of Hematology, 2004, 83 : 319 - 321
  • [38] Successful treatment of B-cell prolymphocytic leukemia with monoclonal anti-CD20 antibody
    Abou Mourad, Y
    Taber, A
    Chehal, A
    Shamseddine, A
    ANNALS OF HEMATOLOGY, 2004, 83 (05) : 319 - 321
  • [39] Experimental therapeutic approach of human diffuse large B-cell lymphoma xenografts by doxycycline, alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
    Assayag, F.
    Brousse, N.
    Couturier, J.
    Macintyre, E.
    Mathiot, C.
    De Plater, L.
    Dewulf, S.
    Vincent-Salomon, A.
    Poupon, M. F.
    Decaudin, D.
    EJC SUPPLEMENTS, 2008, 6 (12): : 26 - 26
  • [40] Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab
    Dillman, RO
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 434 - 447
12345